Literature DB >> 12169128

Eustachian tube function after translabyrinthine vestibular schwannoma surgery.

J A Chiossone-Kerdel1, N Quaranta, D M Baguley, D A Moffat.   

Abstract

The objective of this study was to evaluate the short-term and long-term effect of the obliteration of the middle ear and the Eustachian tube on its function and on middle ear anatomy. Forty-two patients who underwent a translabyrinthine removal of a vestibular schwannoma were randomly selected from the 329 patients operated on in the last 5 years. According to the length of follow-up they were divided in two groups. The Eustachian tube was found to open in 40% of cases 8 months (group mean) after the operation and at 4 years in 70% of cases (group mean) after the operation. The mechanisms leading to the opening of the tube are discussed. In addition the absence of long-term middle ear disorders in those with a permanently closed Eustachian tube showed that the presence of atrophied connective tissue and scar tissue in the middle ear prevented the retraction of the tympanic membrane. Obliteration of the Eustachian tube and middle ear is an easy and rapid procedure, which is temporary in most cases and does not increase the risk of long-term middle ear disease.

Entities:  

Mesh:

Year:  2002        PMID: 12169128     DOI: 10.1046/j.1365-2273.2002.00576.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  2 in total

1.  A Systematic Review of Closure Techniques in Lateral Skull Base Tumor Surgery.

Authors:  Alexander Malone; Michael Randall; K Paul Boyev
Journal:  J Neurol Surg B Skull Base       Date:  2020-05-19

2.  Middle ear ventilation status postoperatively after translabyrinthine resection of vestibular schwannoma with mastoid obliteration and Eustachian tube occlusion: is the Eustachian tube enough to ventilate the middle ear without the mastoid air cell system?

Authors:  James Belyea; Brandon Wickens; Manohar Bance
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.